Electrocardiogram Clinical Validation Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 602 participants.

Also called NCT03492554

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose basic science
Phase
Not applicable
Enrolled
  • 602 participants (enrolled count) (from the registry)
Sponsor
  • Apple Registry lists this organization as the lead sponsor
  • IQVIA Pty Ltd Registry lists this organization as a collaborator
Registry
  • NCT NCT03492554
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03492554. Non-randomized; no masking; primary purpose basic science. Start 2018-03-12 (actual); primary completion 2018-05-14 (actual). Results posted on 2019-07-24.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Electrocardiogram Clinical Validation Study
Intervention (Other)
1-Lead ECG (electrocardiogram)
Intervention (Device)
12-Lead ECG
Lead sponsor
Apple Inc. (class: industry)
Collaborator
IQVIA Pty Ltd (class: industry)

Record details

Record id
cardio:ct-nct03492554
Content hash
5573ce632317cf78b66948bdf44c07c292c1e2a5735c2c0e989b5a0ef0c5ddae